NEW YORK (GenomeWeb News) – Actar, a part of the Karolinska Institutet innovations system in Sweden, has purchased Corning’s Epic System, which it will use in providing label-free drug screening services.
According to Corning, Actar is the first and only company to offer high-throughput, label-free drug screening to academic researchers in Scandanavia and Europe on a fee-for-service basis.
The Epic system uses optical biosensors to measure a broad range of biological responses that are undetectable with conventional methods, said Corning. The firm claims it is the world’s first high-throughput, label-free screening system.
Financial terms of the purchase were not disclosed.